Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ligand Pharmaceuticals, Inc.

http://www.ligand.com

Latest From Ligand Pharmaceuticals, Inc.

No, I Am Spartacus – Embecta Joins The Quell Against GLP-1 Hype

Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned. 

Diabetic Care Drug Delivery Technology

Merck & Co. Seeds Neuroscience Expansion With Caraway Buy

The drug maker will spend up to $610m to acquire Caraway, with a lead product candidate targeting TRPML1, a pathway implicated in a number of neurodegenerative diseases.

Deals M & A

Ovid Looks To Epilepsy – And Beyond – For Candidate OV350

Ovid anticipates its deal to sell part of its interest in soticlestat milestones and royalties to Ligand will take it through 2026, while it looks to develop its KCC2-targeting OV350 for psychiatric disorders.

Sales & Earnings Neurology

Finance Watch: Aiolos Launches With $245m Series A; OrbiMed’s New Funds Total $4.3bn

Private Company Edition: Quarter-over-quarter increases in venture capital have been bolstered by fewer but larger rounds, like the recent $245m series A for Aiolos. Also, OrbiMed raised $4.3bn across three new VC funds, Rampart completed an $85m series A and Atom Bioscience raised an $83m series D. 

Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Biotechnology
    • Drug Discovery Tools
    • Transgenics
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Ab Initio Biotherapeutics
    • Crystal Bioscience, Inc.
    • CyDex Pharmaceuticals, Inc.
    • Icagen Pharmaceuticals, Inc.
    • Metabasis Therapeutics, Inc.
    • Neurogen Corporation
    • Pharmacopeia, Inc.
    • Pfenex Inc.
    • Verrow Pharmaceuticals, Inc.
    • Vernalis Group plc
    • Cita NeuroPharmaceuticals
    • Taurus Biosciences LLC
    • xCella Biosciences, Inc.
UsernamePublicRestriction

Register